TEST CLONE - The First Annual Houston "Prevention Rules for Cardiometabolic Diseases"
Saturday, September 19, 2020
Cardiovascular disease remains the leading cause of death in the United States despite a significant decrease in the morbidity and mortality associated with the disease. Clinical practice and research efforts have placed emphasis on the treatment of cardiovascular disease rather than on the prevention of events. There is a critical need to transition focus from interventional strategies to the prevention of cardiovascular disease, particularly in light of the rapid rise in patients with obesity and diabetes. This educational event aims to provide physicians, fellows, residents, students and other health care professionals with the knowledge and skills in the management of hypercholesterolemia, hypertension and diabetes in the treatment of cardiometabolic disease and prevention of cardiovascular diseases that can be incorporated it into clinical practice.
This course is designed for primary care providers (internal medicine, family practice), cardiologists, allied health professionals (nurse practitioners, physician assistants, pharmacists), and endocrinologists.
At the conclusion of the conference, participants should be able to:
- Implement the new guidelines related to cardiovascular disease risk prediction and management of lipid abnormalities, diabetes and hypertension
- Outline the advances and guidelines in the management of lipid (cholesterol) related abnormalities and list therapies int he horizon
- Discuss recent advances in the management of diabetes mellitus, and the available options for the medical management of diabetes mellitus with a specific focus on their cardiovascular benefit and outline the therapies on the horizon
- Summarize the current clinical approach towards the management of hypertension and identify patients in whom intensive blood pressure management could be pursued
Lectures ▪ Panel Discussion ▪ Question and Answer Sessions
Evaluation by questionnaire will address program content, presentation, and possible bias.
SATURDAY, SEPTEMBER 19, 2020
CONTEMPORARY MANAGEMENT OF DYSLIPIDEMIA
The Lipid Guideline Approach Towards Primary and Secondary Prevention
Salim Virani, M.D., Ph.D.
Imaging to Assess Cardiovascular Disease Risk
Khurram Nasir, M.D.
Statin Intolerance: Definition and Approaches
Vijay Nambi, M.D., Ph.D.
A Deep Dive into Management of Hypertriglyceridemia
Peter Jones, M.D.
PCKS9 – Inhibitors
Pam Taub, M.D.
Lipoprotein (a) and novel biologics: The Next Frontiers in Lipid Management
Christie Ballantyne, M.D.
LIFESTYLE CHOICES, CHALLENGES, AND GUIDELINES
Weight Loss – Tips, Tricks, and Recommendations
Peter Jones, M.D.
Physical Activity – Recommendations and How to Achieve
John Foreyt, M.D.
CONTEMPORARY DIABETES MANAGEMENT
Mandeep Bajaj, M.D.
Diabetes Management in Cardiovascular Disease Prevention
Robert Eckel M.D.
Diabetes Management in Heart Failure
David Aguilar M.D.
Addison Taylor, M.D., M.P.H.
Resistant Hypertension and the Future Landscape in the Management of Hypertension
Sandra Taler, M.D.
Conference offered virtually via Zoom.
Connection information will be emailed to registrants the week of the conference.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.75 AMA PRA Category 1 Credit™
- 6.75 Attendance